✨ Free AI Report
Laboratorios Farmaceuticos Rovi: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Laboratorios Farmaceuticos Rovi
Company Research

Laboratorios Farmaceuticos Rovi: Business Overview, Financials & Competitive Analysis

Laboratorios Farmaceuticos Rovi scores 6/10 on the AskCyborg Cyborg Score (Mixed). Established specialty pharma player with valuable biosimilar portfolio and manufacturing assets, but facing near-term margin pressure and EBIT decline requiring strategic execution to restore growth. In 2024, revenue declined 7.93% to €763.75M and earnings fell 19.64% to €136.88M. Positive interest cover and low net debt to EBITDA of 0.40.

What is Laboratorios Farmaceuticos Rovi's industry? Laboratorios Farmaceuticos Rovi (rovi.es) operates in Specialty Pharmaceuticals & Contract Manufacturing. AskCyborg classifies Laboratorios Farmaceuticos Rovi under Specialty Pharmaceuticals & Contract Manufacturing in its company registry.

Laboratorios Farmaceuticos Rovi specializes in the research, development, manufacturing and marketing of biological medications and specialty drugs. The company has subsidiaries in Portugal, Germany, the United Kingdo...

6/ 10Mixed

Cyborg Score thesis

Established specialty pharma player with valuable biosimilar portfolio and manufacturing assets, but facing near-term margin...

Read the full analyst-debate transcript →
Industry Specialty Pharmaceuticals & Contract Manufacturing
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Laboratorios Farmaceuticos Rovi Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Laboratorios Farmaceuticos Rovi

AskCyborg analysts argue the bull and bear cases for Laboratorios Farmaceuticos Rovi across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Laboratorios Farmaceuticos Rovi OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Laboratorios Farmaceuticos Rovi Overview

Pro stress-test →

Laboratorios Farmaceuticos Rovi specializes in the research, development, manufacturing and marketing of biological medications and specialty drugs. The company has subsidiaries in Portugal, Germany, the United Kingdom, Italy, France and Poland and has a diversified marketing portfolio of more than 40 products. As a Spanish pharmaceutical leader, Rovi serves cardiology, CNS, respiratory, and diagnostic imaging markets with both proprietary formulations and biosimilars.

Strategic Profile

Pro stress-test →

Rovi's flagship product Bemiparin is present in 89 countries, and the company markets an enoxaparin biosimilar developed in-house across 38 countries. Rovi continues to develop the ISM® Platform technology, a leading-edge line of research in the field of prolonged drug release with proven advantages. The company leverages vertical integration, proprietary manufacturing capabilities, and international expansion to compete in competitive specialty pharma and contract manufacturing markets.

Competitive Landscape

Pro stress-test →

Rovi competes in the European specialty pharmaceuticals and contract manufacturing sectors against both large multinational pharma companies and mid-cap players. Key Spanish/European competitors include Almirall, Faes Farma, and Reig Jofre, as well as larger contract manufacturing players. Rovi's differentiation stems from its biosimilar portfolio (Bemiparin, Enoxaparin), proprietary ISM platform technology, and integrated manufacturing capabilities serving cardiology, diagnostics, and CNS markets.

Industry Context

Laboratorios Farmaceuticos Rovi operates in Specialty Pharmaceuticals & Contract Manufacturing.

Key facts

Founded: 1946 · Headquarters: Madrid, Spain · Revenue: €763.75M (2024) · Market cap: €2.84B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Laboratorios Farmaceuticos Rovi.

  • EBIT declined 16% year-over-year; repeated performance like this could lead to stock difficulties.
  • In Q1 2025, the company obtained positive results in two phase one trials, enabling progress towards phase III clinical trials for ISM platform formulations.
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • Q1 2025Positive Phase I trial results for ISM platform-based formulations with progress to Phase III trials
  • 2024Revenue declined to €763.75M (-7.93% YoY) amid market and competitive pressures
  • +1 moreTrack every material event for Laboratorios Farmaceuticos Rovi as it happens. Explore monitoring →
Get alerted when Laboratorios Farmaceuticos Rovi has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Specialty Pharma PortfolioSpanish pharmaceutical competitor in dermatology and respiratory→Specialty Pharma & GenericsSpanish pharmaceutical company in specialty and generic markets→Contract Manufacturing & PharmaEuropean pharma and contract manufacturing player→Biosimilars & InjectablesLarger Spanish pharma/biotech company in plasma products and injectables→

Compare Laboratorios Farmaceuticos Rovi with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Laboratorios Farmaceuticos Rovi operates in Specialty Pharmaceuticals & Contract Manufacturing. See how the rest of the sector scores on the Cyborg framework.

Browse Specialty Pharmaceuticals & Contract Manufacturing research →
NEW · MCP server

Ask your AI assistant about Laboratorios Farmaceuticos Rovi

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Laboratorios Farmaceuticos Rovi and its top competitor on Cyborg Score”
“What did Laboratorios Farmaceuticos Rovi do this quarter?”
“Is Laboratorios Farmaceuticos Rovi a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Laboratorios Farmaceuticos Rovi do?+
Laboratorios Farmaceuticos Rovi specializes in the research, development, manufacturing and marketing of biological medications and specialty drugs. The company has subsidiaries in Portugal, Germany, the United Kingdo...
What is Laboratorios Farmaceuticos Rovi's Cyborg Score?+
Laboratorios Farmaceuticos Rovi has a Cyborg Score of 6/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Laboratorios Farmaceuticos Rovi's main competitors?+
Named competitors include Specialty Pharma Portfolio, Specialty Pharma & Generics, Contract Manufacturing & Pharma, Biosimilars & Injectables. The full competitive landscape is in the AskCyborg report.
How can I get the full Laboratorios Farmaceuticos Rovi research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Laboratorios Farmaceuticos Rovi research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Laboratorios Farmaceuticos Rovi over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Specialty Pharmaceuticals & Contract Manufacturing research

Companies in the same sector and named competitors, ranked by Cyborg Score.

6Laboratorios Farmaceuticos Rovi